Article

VLPs Containing Stalk Domain and Ectodomain of Matrix Protein 2 of Influenza Induce Protection in Mice

2022-10-11

Abstract excerpt

<h4>Background: </h4> Due to antigenic drift, current influenza vaccines provide limited protection against circulating influenza viruses, and vaccines with broad cross protection are urgently needed. Hemagglutinin (HA) stalk domain and ectodomain of matrix protein 2 are highly conserved among influenza viruses and have great potential for use in a universal vaccine. Methods In this study, we co-expressed the sta...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9421dec0-8b02-5bf0-96e2-c6b6f197dcbb
DOI: 10.21203/rs.3.rs-2127390/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

VLPs Containing Stalk Domain and Ectodomain of Matrix Protein 2 of Influenza Induce Protection in MiceDOI 10.21203/rs.3.rs-2127390/v1Read

Hemagglutinin Stalk-based Monoclonal Antibody Elicits Broadly Reactivity Against Group 1 Influenza A VirusSemantic proximity Read

A Low-Dose Triple Antibody Cocktail Against the Ectodomain of the Matrix Protein 2 of Influenza A Is A Universally Effective and Viral Escape Mutant Resistant Therapeutic AgentSemantic proximity Read

Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of MiceSemantic proximity Read

Single-component multilayered self-assembling protein nanoparticles displaying extracellular domains of matrix protein 2 as a pan-influenza A vaccineSemantic proximity Read

A VSV-vector vaccine simultaneously targeting H5N1 hemagglutinin (HA) and matrix protein 2 (M2) induces robust neutralizing and ADCC antibody responses and provides full protection against lethal H5N1 infection in a mouse modelSemantic proximity Read

Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine developmentSemantic proximity Read

Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1Semantic proximity Read

Virus-like particles as universal influenza vaccinesSemantic proximity Read

Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in miceSemantic proximity Read

In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression.Semantic proximity Read

Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBDSemantic proximity Read

Enhanced Protection from SARS-CoV-2 Variants by MVA-Based Vaccines Expressing Matched or Mismatched S Proteins Administered Intranasally to hACE2 MiceSemantic proximity Read